Skip to content

Contact +44 (0) 20 7060 7474 email us

Medical Devices

Eli Lilly and Company Medical Equipment Company Share Analysis

 

Publication Date September 2008
Publisher Global Markets Direct
Product Type Report
Pages 84
ISBN Number not applicable
Product Code GMD01329

Price

£665.00
approximately: $999 | €729

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

Eli Lilly and Company Medical Equipment Company Share Analysis

Summary

This report is an essential source for data, analysis and strategic insight into Eli Lilly and Company. The report provides key information relating to market share by sector and country, financial, SWOT and value chain analysis of the company. The report examines company's business structure and operations, history and products, and provides an analysis of its key revenue lines. It inspects the company's strategy, both in terms of its value chain positioning and strategic strengths and weaknesses.

Scope

  • Revenues for the markets and sub-sectors Eli Lilly and Company operates in by country and region.
  • Detailed breakdowns of revenues and market share benchmarked against competitors.
  • Profiles of the pipeline of products that the company is developing.
  • Critical analysis of the company's strengths, weaknesses opportunities and threats and positioning on the value chain.
  • Provides summary analysis of key revenue lines and strategy.
  • Details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions.
  • Latest mergers and acquisitions, partnerships or financings of the company, including debt, equity or venture finance.

Reasons to buy

  • A single source to fulfill all of your business and competitor intelligence needs
  • Research your competitors business structure, strategy and prospects.
  • Counter your competitors strengths and target their weaknesses.
  • Identify your competitors key revenue streams by market and geography.
  • Identify and assess potential corporate and investment opportunities
  • Support sales activities by understanding your customers businesses better.
  • Identify potential competitor products before they reach market.
  • Qualify prospective partners and suppliers.

Contents

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What is this report about
    • 2.2 Definitions
      • 2.2.1 Diabetes Care Devices
        • 2.2.1.1 Insulin Delivery
  • 3 Company Snapshot
    • 3.1 Key Information
    • 3.2 Company Overview
    • 3.3 Financial Performance
    • 3.4 SWOT Snapshot
  • 4 Business Description
    • 4.1 Business Overview
    • 4.2 Pharmaceutical Products
      • 4.2.1 Overview
      • 4.2.2 Financials
      • 4.2.3 Market View
      • 4.2.4 Key Strategies
    • 4.3 Major Products and Services
      • 4.3.1 Overview
  • 5 History
  • 6 Business Strategy
    • 6.1 Mission Statement
    • 6.2 Strategy
    • 6.3 Corporate Social Responsibility
      • 6.3.1 Overview
      • 6.3.2 Specific CSR Initiatives
  • 7 Value Chain Analysis
    • 7.1 Manufacturing
      • 7.1.1 In House Manufacturing
      • 7.1.2 Outsourcing
    • 7.2 Product Development
      • 7.2.1 Regulatory Approvals
      • 7.2.2 Clinical Trials
      • 7.2.3 Research and Development
    • 7.3 Sales and Marketing
      • 7.3.1 Partnerships and Alliances
      • 7.3.2 Licensing Agreements
      • 7.3.3 E-distribution
  • 8 SWOT Analysis
    • 8.1 Overview
    • 8.2 Eli Lilly and Company Strengths
      • 8.2.1 Increasing Revenues
      • 8.2.2 Extensive R&D Activities
      • 8.2.3 High Returns
    • 8.3 Eli Lilly and Company Weaknesses
      • 8.3.1 Patent Litigations
      • 8.3.2 Government Investigations
      • 8.3.3 Lack of Geographic Diversity
    • 8.4 Eli Lilly and Company Opportunities
      • 8.4.1 MDR-TB Partnership
      • 8.4.2 FDA Approvals
      • 8.4.3 Acquisitions
    • 8.5 Eli Lilly and Company Threats
      • 8.5.1 Regulatory Changes
      • 8.5.2 Increasing Popularity of Generic Drugs
  • 9 Competitors
  • 10 Eli Lilly and Company Medical Equipment Market Share Analysis
    • 10.1 Eli Lilly and Company, Global, Market Share (2006)
    • 10.2 Eli Lilly and Company, APAC, Market Share (2006)
    • 10.3 Eli Lilly and Company, Europe, Market Share (2006)
    • 10.4 Eli Lilly and Company, MEA, Market Share (2006)
    • 10.5 Eli Lilly and Company, North America, Market Share (2006)
    • 10.6 Eli Lilly and Company, SCA, Market Share (2006)
  • 11 Revenue Analysis
    • 11.1 Revenue by Segment
    • 11.2 Revenue by Geography
  • 12 Financial and Operational Review
    • 12.1 Financial Statements
    • 12.2 Financial Ratios
  • 13 Share Holding Structure
  • 14 Key Employees
  • 15 Key Employee Biographies
  • 16 Company Statement
  • 17 Locations And Subsidiaries
    • 17.1 Head Office
    • 17.2 Other Locations & Subsidiaries
  • 18 Financial Deals Landscape
    • 18.1 Asset Purchase
      • 18.1.1 CMC Biopharmaceuticals To Acquire ICOS Biologics Operation In Bothell From Eli Lilly and Company
    • 18.2 Acquisition
      • 18.2.1 Eli Lilly and Company Acquires Hypnion
      • 18.2.2 Eli Lilly and Company Acquires ICOS
    • 18.3 Venture Financing
      • 18.3.1 Inoveon Secures $16 Million In Series B Financing
  • 19 Recent Developments
    • 19.1 Strategy And Business Planning
      • 19.1.1 Aug 20, 2008: Eli Lilly Completes Acquisition Of SGX
      • 19.1.2 Nov 28, 2006: APNS Collaborates With Eli Lilly To Develop AD
    • 19.2 Financial Announcements
      • 19.2.1 Jul 24, 2008: Eli Lilly Reports 2Q 2008 Results
      • 19.2.2 Jun 25, 2008: Eli Lilly To Declare Q2 2008 Results
      • 19.2.3 Jun 20, 2008: Eli Lilly Declares Quarterly Dividend
      • 19.2.4 Apr 21, 2008: Eli Lilly Reports Q1 2008 Results
      • 19.2.5 Apr 21, 2008: Eli Lilly Declares Quarterly Dividend
      • 19.2.6 Apr 02, 2008: Eli Lilly To Declare Q1 2008 Results
      • 19.2.7 Jan 29, 2008: Eli Lilly Reports Q4 2007 Results
      • 19.2.8 Jan 04, 2008: Eli Lilly To Declare Q4 And Year End 2007 Results
      • 19.2.9 Dec 17, 2007: Eli Lilly Declares Quarterly Dividend
      • 19.2.10 Dec 17, 2007: Eli Lilly Increases Quarterly Dividend
      • 19.2.11 Oct 18, 2007: Eli Lilly Declares Q3 2007 Results
      • 19.2.12 Oct 15, 2007: Eli Lilly Declares Quarterly Dividend
      • 19.2.13 Jul 24, 2007: Eli Lilly Declares Q2 2007 Results
      • 19.2.14 Jun 21, 2007: Eli Lilly Declares Quarterly Dividend
      • 19.2.15 Apr 16, 2007: Eli Lilly Declares Q1 2007 Results
      • 19.2.16 Apr 16, 2007: Eli Lilly Declares Quarterly Dividend
      • 19.2.17 Jan 31, 2007: Eli Lilly Declares Q4 2006 Results
    • 19.3 Research And Development
      • 19.3.1 Nov 28, 2006: APNS Collaborates With Eli Lilly To Develop AD
    • 19.4 Corporate Communications
      • 19.4.1 May 21, 2008: Eli Lilly Announces Senior Management Changes
      • 19.4.2 Feb 19, 2008: Eli Lilly Announces Board changes
      • 19.4.3 Dec 18, 2007: Eli Lilly CEO Retires
      • 19.4.4 Dec 18, 2007: Eli Lilly CEO To Retire
    • 19.5 Product News
      • 19.5.1 Feb 21, 2008: Eli Lilly Launches KwikPen For Humalog And Humalog Mixtures
  • 20 Appendix
    • 20.1 Global Markets Direct Research Methodology
    • 20.2 Coverage
    • 20.3 Secondary Research
    • 20.4 Primary Research
    • 20.5 Models
    • 20.6 Forecasts
    • 20.7 Expert Panels
    • 20.8 Market Revenue Chapters
      • 20.8.1 Abbreviations
      • 20.8.2 Currency Conversions
    • 20.9 About Global Markets Direct
    • 20.10 Contact Us
    • 20.11 Disclaimer
  • 1.1 List of Tables
    • Table 1: Eli Lilly and Company, Key Facts, 2007
    • Table 2: Eli Lilly and Company, SWOT Analysis, 2007
    • Table 3: Eli Lilly and Company, Diabetes Care Devices by Category, Global, Revenue ($ mn) and Market Share (%), 2006
    • Table 4: Eli Lilly and Company, Diabetes Care Devices by category, APAC, Revenue ($ mn) and Market Share (%), 2006
    • Table 5: Eli Lilly and Company, Diabetes Care Devices by category, Australia, Revenue ($ mn) and Market Share (%), 2006
    • Table 6: Eli Lilly and Company, Diabetes Care Devices by category, China, Revenue ($ mn) and Market Share (%), 2006
    • Table 7: Eli Lilly and Company, Diabetes Care Devices by category, India, Revenue ($ mn) and Market Share (%), 2006
    • Table 8: Eli Lilly and Company, Diabetes Care Devices by category, Japan, Revenue ($ mn) and Market Share (%), 2006
    • Table 9: Eli Lilly and Company, Diabetes Care Devices by category, New Zealand, Revenue ($ mn) and Market Share (%), 2006
    • Table 10: Eli Lilly and Company, Diabetes Care Devices by category, Republic of Korea, Revenue ($ mn) and Market Share (%), 2006
    • Table 11: Eli Lilly and Company, Diabetes Care Devices by category, Taiwan, Revenue ($ mn) and Market Share (%), 2006
    • Table 12: Eli Lilly and Company, Diabetes Care Devices by category, Europe, Revenue ($ mn) and Market Share (%), 2006
    • Table 13: Eli Lilly and Company, Diabetes Care Devices by category, Austria, Revenue ($ mn) and Market Share (%), 2006
    • Table 14: Eli Lilly and Company, Diabetes Care Devices by category, Belgium, Revenue ($ mn) and Market Share (%), 2006
    • Table 15: Eli Lilly and Company, Diabetes Care Devices by category, Czech Republic, Revenue ($ mn) and Market Share (%), 2006
    • Table 16: Eli Lilly and Company, Diabetes Care Devices by category, Finland, Revenue ($ mn) and Market Share (%), 2006
    • Table 17: Eli Lilly and Company, Diabetes Care Devices by category, France, Revenue ($ mn) and Market Share (%), 2006
    • Table 18: Eli Lilly and Company, Diabetes Care Devices, Germany, Revenue ($ mn) and Market Share (%), 2006
    • Table 19: Eli Lilly and Company, Diabetes Care Devices by category, Greece, Revenue ($ mn) and Market Share (%), 2006
    • Table 20: Eli Lilly and Company, Diabetes Care Devices by category, Hungary, Revenue ($ mn) and Market Share (%), 2006
    • Table 21: Eli Lilly and Company, Diabetes Care Devices by category, Ireland, Revenue ($ mn) and Market Share (%), 2006
    • Table 22: Eli Lilly and Company, Diabetes Care Devices by category, Italy, Revenue ($ mn) and Market Share (%), 2006
    • Table 23: Eli Lilly and Company, Diabetes Care Devices by category, Netherlands, Revenue ($ mn) and Market Share (%), 2006
    • Table 24: Eli Lilly and Company, Diabetes Care Devices by category, Norway, Revenue ($ mn) and Market Share (%), 2006
    • Table 25: Eli Lilly and Company, Diabetes Care Devices by category, Poland, Revenue ($ mn) and Market Share (%), 2006
    • Table 26: Eli Lilly and Company, Diabetes Care Devices by category, Portugal, Revenue ($ mn) and Market Share (%), 2006
    • Table 27: Eli Lilly and Company, Diabetes Care Devices by category, Russia, Revenue ($ mn) and Market Share (%), 2006
    • Table 28: Eli Lilly and Company, Diabetes Care Devices by category, Spain, Revenue ($ mn) and Market Share (%), 2006
    • Table 29: Eli Lilly and Company, Diabetes Care Devices by category, Sweden, Revenue ($ mn) and Market Share (%), 2006
    • Table 30: Eli Lilly and Company, Diabetes Care Devices by category, Switzerland, Revenue ($ mn) and Market Share (%), 2006
    • Table 31: Eli Lilly and Company, Diabetes Care Devices by category, Turkey, Revenue ($ mn) and Market Share (%), 2006
    • Table 32: Eli Lilly and Company, Diabetes Care Devices by category, United Kingdom, Revenue ($ mn) and Market Share (%), 2006
    • Table 33: Eli Lilly and Company, Diabetes Care Devices by category, MEA, Revenue ($ mn) and Market Share (%), 2006
    • Table 34: Eli Lilly and Company, Diabetes Care Devices by category, Egypt, Revenue ($ mn) and Market Share (%), 2006
    • Table 35: Eli Lilly and Company, Diabetes Care Devices by category, Israel, Revenue ($ mn) and Market Share (%), 2006
    • Table 36: Eli Lilly and Company, Diabetes Care Devices by category, South Africa, Revenue ($ mn) and Market Share (%), 2006
    • Table 37: Eli Lilly and Company, Diabetes Care Devices by category, UAE, Revenue ($ mn) and Market Share (%), 2006
    • Table 38: Eli Lilly and Company, Diabetes Care Devices by category, North America, Revenue ($ mn) and Market Share (%), 2006
    • Table 39: Eli Lilly and Company, Diabetes Care Devices by category, Canada, Revenue ($ mn) and Market Share (%), 2006
    • Table 40: Eli Lilly and Company, Diabetes Care Devices by category, USA, Revenue ($ mn) and Market Share (%), 2006
    • Table 41: Eli Lilly and Company, Diabetes Care Devices by category, SCA, Revenue ($ mn) and Market Share (%), 2006
    • Table 42: Eli Lilly and Company, Diabetes Care Devices by category, Brazil, Revenue ($ mn) and Market Share (%), 2006
    • Table 43: Eli Lilly and Company, Diabetes Care Devices by category, Chile, Revenue ($ mn) and Market Share (%), 2006
    • Table 44: Eli Lilly and Company, Diabetes Care Devices by category, Mexico, Revenue ($ mn) and Market Share (%), 2006
    • Table 45: Eli Lilly and Company, Revenue by Segment, USD Million, 2003-2007
    • Table 46: Eli Lilly and Company, Revenue by Geography, USD Million, 2003-2007
    • Table 47: Eli Lilly and Company, Financial Statements, USD Million, 2003-2007
    • Table 48: Eli Lilly and Company, Financial Ratios, USD Million, 2003-2007
    • Table 49: Eli Lilly and Company, Share Holding Structure
    • Table 50: Eli Lilly and Company, Key Employees, 2007
    • Table 51: Eli Lilly and Company, Other Locations
    • Table 52: Eli Lilly and Company, Subsidiaries
    • Table 53: Abbreviations used in the Market Revenue Chapters
    • Table 54: Currency Conversion used in the Market Revenue Chapters
  • 1.2 List of Figures
    • Figure 1: Eli Lilly and Company, Value Chain Analysis
    • Figure 2: Eli Lilly and Company, Diabetes Care Devices by Category, Global, Share of Market (%), 2006
    • Figure 3: Eli Lilly and Company, Diabetes Care Devices by Category, APAC, Share of Market (%), 2006
    • Figure 4: Eli Lilly and Company, Diabetes Care Devices by Category, Europe, Share of Market (%), 2006
    • Figure 5: Eli Lilly and Company, Diabetes Care Devices by Category, MEA, Share of Market (%), 2006
    • Figure 6: Eli Lilly and Company, Diabetes Care Devices by Category, North America, Share of Market (%), 2006
    • Figure 7: Eli Lilly and Company, Diabetes Care Devices by Category, SCA, Share of Market (%), 2006
    • Figure 8: Global Markets Direct Methodology
Product Features / Use
Scope Expert Insight/Opinion
Profiles In-depth Company Insight
Features Primary Research Data